The largest database of trusted experimental protocols

Jnk inhibitor sp 600125

Manufactured by Cayman Chemical
Sourced in United States

JNK inhibitor SP 600125 is a selective, reversible, and ATP-competitive c-Jun N-terminal kinase (JNK) inhibitor. It is commonly used in research applications to study the role of the JNK signaling pathway.

Automatically generated - may contain errors

4 protocols using jnk inhibitor sp 600125

1

Inhibition of JNK Signaling in Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We purchased JNK inhibitor SP600125 from Cayman Chemical (Ann Arbor, MI, USA), and transforming growth factor alpha (TGF‐α) from R&D Systems (Minneapolis, MN, USA). Primary antibodies used in immunohistochemical and immunofluorescence assays included rabbit anti‐phospho‐JNK antibody (1:50; Cell Signaling Technology, Danvers, MA, USA), rat anti‐mouse CD45 antibody (1:50; BD Biosciences, San Jose, CA, USA), rat anti‐mouse F4/80 antibody (1:100; eBioscience, San Diego, CA, USA), rabbit anti‐Ki‐67 antibody (1:100; Abcam, Cambridge, UK), mouse anti‐α‐smooth muscle actin (α‐SMA) antibody (1:50; Santa Cruz, Santa Cruz, CA, USA), biotin hamster anti‐mouse CD11c antibody (1:100; BD Biosciences), rabbit anti‐cleaved caspase3 antibody (1:1600; Cell Signaling Technology) and rabbit anti‐CD8 antibody (clone EP1150Y, 1:250; Epitomics, Burlingame, CA, USA). Primary antibodies used in immunoblotting analysis included rabbit anti‐phospho‐JNK antibody (1:1000; Cell Signaling Technology), rabbit anti‐JNK antibody (1:1000; Cell Signaling Technology), rabbit anti‐phospho‐Stat3 antibody (1:2000; Cell Signaling Technology) and mouse anti‐Stat3 antibody (1:1000; Cell Signaling Technology).
+ Open protocol
+ Expand
2

Cell Culture and Treatment Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
NMuMG cells, female, a kind gift from Prof. Rik Derynck (University of California San Francisco), and 293 FT cells, female, (Thermo Fisher Scientific) were grown as in James et al. (2018) . Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs), male, and culture media were obtained from Axol BioSciences and maintained according to manufacturer’s instructions. Cells were maintained in a humidified atmosphere of 5% CO2 at 37°C, for hypoxic studies O2 was dropped to 1% in a tri-gas incubator. Cell treatments: TGF-β1 (2 ng/ml; Humanzyme), p38 inhibitor SB 202190 (20 μM; Cayman), JNK inhibitor SP 600125 (20 μM; Cayman), Erk½ inhibitor SCH 772984 (0.1 μM; Cayman), or vehicle (DMSO; Sigma).
+ Open protocol
+ Expand
3

Investigating TGF-β Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
NMuMG cells were a kind gift from Rik Derynck (University of California, San Francisco) and maintained in DMEM+Glutamax supplemented with 10% fetal bovine serum (FBS), sodium pyruvate, nonessential amino acids (Thermo Scientific), bovine insulin solution (5 μg/ml; Sigma) and MycoZAP (Lonza). MycoZAP is included to prevent Mycoplasma contamination. Cells were maintained in a humidified atmosphere of 5% CO2 at 37°C. For experiments, cells were plated at 1.6 × 104 cells/cm2 in 100-mm plates or six-well dishes for protein harvesting and eight-well chamber slides for imaging. Cells were incubated for 24 h before addition of media containing one of the following treatments: TGF-β1 (2 ng/ml; Humanzyme), the TβR1 blocker SB 431542 (SB; 5 µM; Sigma), Smad3 inhibitor SIS3 (10 µM; Selleckchem), p38 inhibitor SB 202190 (20 µM; Cayman), JNK inhibitor SP 600125 (20 µM; Cayman), ERK1/2 inhibitor SCH 772984 (0.1 µM; Cayman), or vehicle (veh; dimethyl sulfoxide [DMSO]). 293FT cells were obtained from Thermo Scientific and maintained in DMEM+Glutamax supplemented with 10% FBS, sodium pyruvate, nonessential amino acids (Thermo Scientific), and MycoZAP (Lonza).
+ Open protocol
+ Expand
4

Cell Culture and Treatment Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
NMuMG cells, female, a kind gift from Prof. Rik Derynck (University of California San Francisco), and 293 FT cells, female, (Thermo Fisher Scientific) were grown as in James et al. (2018) . Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs), male, and culture media were obtained from Axol BioSciences and maintained according to manufacturer’s instructions. Cells were maintained in a humidified atmosphere of 5% CO2 at 37°C, for hypoxic studies O2 was dropped to 1% in a tri-gas incubator. Cell treatments: TGF-β1 (2 ng/ml; Humanzyme), p38 inhibitor SB 202190 (20 μM; Cayman), JNK inhibitor SP 600125 (20 μM; Cayman), Erk½ inhibitor SCH 772984 (0.1 μM; Cayman), or vehicle (DMSO; Sigma).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!